申请人:Nauchno-Issledovatelsky Institut Farmakologii Rossiiskoi Akademii Meditsinskikh Nauk
公开号:US06376666B1
公开(公告)日:2002-04-23
2-mercaptobenzimidazole derivatives of the general formula
wherein: N=0,2,3; R-hydrogen atom, aralkyls; R1-lower alkyls, alkenyls, dialkylamino, a saturated amine monocyclic residue which may contain an additional heteroatom; R2 and R3 are equal or different and stand for hydrogen atoms, lower alkyls, alkoxy in various positions, and their pharmaceutically acceptable salts, according to the results of pharmacological research study exhibit a pronounced anxiolytic, sedative, antiischemia and antiarrhythmia effect and have certain advantages over popular clinic preparations. These can find a wide variety of application for treatment of patients suffering from various mental derangements and heart ischemia.
通式为的2-巯基苯并咪唑衍生物中:N=0,2,3;R-氢原子,芳基烷基;R1-较低的烷基,烯基,二烷基氨基,饱和胺单环残基,该残基可能含有额外的杂原子;R2和R3相等或不同,代表氢原子,较低的烷基,各种位置的烷氧基,以及它们的药用盐。根据药理研究结果,这些衍生物表现出明显的抗焦虑、镇静、抗缺血和抗心律失常作用,并且与流行的临床制剂相比具有某些优势。这些可以广泛应用于治疗患有各种心理失调和心脏缺血的患者。